FDA-cleared host-immune response assay that differentiates bacterial from viral infections in 15 minutes using serum or venous whole blood. Applies machine learning to immune system signaling to provide actionable diagnostic insights for improved antibiotic stewardship and patient outcomes.
Manufactured by
MeMed
Israel
MeMed is a leader in host response technologies that decode the body's complex signals into simple insights to improve patient outcomes. Leveraging expertise in host-response profiling and machine-learning algorithms, MeMed has developed a portfolio of tests addressing complex clinical dilemmas. The company has created MeMed Key®, a point-of-need rapid measurement platform ensuring timely availability of novel tests during clinician decision-making workflows. MeMed BV®, run on the MeMed Key platform, accurately determines the likelihood of bacterial or viral infections to enable improved patient management. Based on computational integration of bacterial and viral-responsive immune proteins, MeMed Key delivers MeMed BV results in 15 minutes from serum. This test has been clinically validated on thousands of patients, is CE-marked, and FDA cleared.
© 2026 Suplivia · Home · Browse Products